Selected research
Industry Research
Meropenem Powder Injection Industry Research Report 2026
Market perspective
The global Meropenem Powder Injection market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Meropenem Powder Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Meropenem Powder Injection is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Meropenem Powder Injection is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Meropenem Powder Injection include Chongqing Shenghuaxi Pharma, Haikou Pharmaceutical Factory, Luoxin Pharna, Hisun, Shanghai Pharma, United Laboratories, Sumitomo Pharma, PKU HealthCare and Pfizer, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Meropenem Powder Injection market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Meropenem Powder Injection Market by Company
Chongqing Shenghuaxi Pharma
Haikou Pharmaceutical Factory
Luoxin Pharna
Hisun
Shanghai Pharma
United Laboratories
Sumitomo Pharma
PKU HealthCare
Pfizer
Joincare
Intelicure Lifesciences
CSPC Pharmaceutical Group
Meropenem Powder Injection Segment by Type
1.0g per Vial
0.50g per Vial
0.25g per Vial
Meropenem Powder Injection Segment by Application
Skin and Soft Tissue Infections（SSTI）
Meningitis
Urinary Tract Infection
Gynecological Infections
Septicemia
Other
Meropenem Powder Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Meropenem Powder Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Meropenem Powder Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Meropenem Powder Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Meropenem Powder Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Meropenem Powder Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Meropenem Powder Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1.0g per Vial
- 0.50g per Vial
- 0.25g per Vial
Applications
- Skin and Soft Tissue Infections（SSTI）
- Meningitis
- Urinary Tract Infection
- Gynecological Infections
- Septicemia
- Other
Companies covered
- Chongqing Shenghuaxi Pharma
- Haikou Pharmaceutical Factory
- Luoxin Pharna
- Hisun
- Shanghai Pharma
- United Laboratories
- Sumitomo Pharma
- PKU HealthCare
- Pfizer
- Joincare
- Intelicure Lifesciences
- CSPC Pharmaceutical Group
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Meropenem Powder Injection Market Size (2021-2032)
- 2.2.2 Global Meropenem Powder Injection Sales (2021-2032)
- 2.2.3 Global Meropenem Powder Injection Market Average Price (2021-2032)
- 2.3 Meropenem Powder Injection by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 1.0g per Vial
- 2.3.3 0.50g per Vial
- 2.3.4 0.25g per Vial
- 2.4 Meropenem Powder Injection by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Skin and Soft Tissue Infections（SSTI）
- 2.4.3 Meningitis
- 2.4.4 Urinary Tract Infection
- 2.4.5 Gynecological Infections
- 2.4.6 Septicemia
- 2.4.7 Other
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Meropenem Powder Injection Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Meropenem Powder Injection Sales (K Units) of Manufacturers (2021-2026)
- 3.3 Global Meropenem Powder Injection Revenue of Manufacturers (2021-2026)
- 3.4 Global Meropenem Powder Injection Average Price by Manufacturers (2021-2026)
- 3.5 Global Meropenem Powder Injection Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Meropenem Powder Injection, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Meropenem Powder Injection, Product Type & Application
- 3.8 Global Manufacturers of Meropenem Powder Injection, Established Date
- 3.9 Global Meropenem Powder Injection Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Chongqing Shenghuaxi Pharma
- 4.1.1 Chongqing Shenghuaxi Pharma Company Information
- 4.1.2 Chongqing Shenghuaxi Pharma Business Overview
- 4.1.3 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Chongqing Shenghuaxi Pharma Meropenem Powder Injection Product Portfolio
- 4.1.5 Chongqing Shenghuaxi Pharma Recent Developments
- 4.2 Haikou Pharmaceutical Factory
- 4.2.1 Haikou Pharmaceutical Factory Company Information
- 4.2.2 Haikou Pharmaceutical Factory Business Overview
- 4.2.3 Haikou Pharmaceutical Factory Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Haikou Pharmaceutical Factory Meropenem Powder Injection Product Portfolio
- 4.2.5 Haikou Pharmaceutical Factory Recent Developments
- 4.3 Luoxin Pharna
- 4.3.1 Luoxin Pharna Company Information
- 4.3.2 Luoxin Pharna Business Overview
- 4.3.3 Luoxin Pharna Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Luoxin Pharna Meropenem Powder Injection Product Portfolio
- 4.3.5 Luoxin Pharna Recent Developments
- 4.4 Hisun
- 4.4.1 Hisun Company Information
- 4.4.2 Hisun Business Overview
- 4.4.3 Hisun Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Hisun Meropenem Powder Injection Product Portfolio
- 4.4.5 Hisun Recent Developments
- 4.5 Shanghai Pharma
- 4.5.1 Shanghai Pharma Company Information
- 4.5.2 Shanghai Pharma Business Overview
- 4.5.3 Shanghai Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Shanghai Pharma Meropenem Powder Injection Product Portfolio
- 4.5.5 Shanghai Pharma Recent Developments
- 4.6 United Laboratories
- 4.6.1 United Laboratories Company Information
- 4.6.2 United Laboratories Business Overview
- 4.6.3 United Laboratories Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 United Laboratories Meropenem Powder Injection Product Portfolio
- 4.6.5 United Laboratories Recent Developments
- 4.7 Sumitomo Pharma
- 4.7.1 Sumitomo Pharma Company Information
- 4.7.2 Sumitomo Pharma Business Overview
- 4.7.3 Sumitomo Pharma Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Sumitomo Pharma Meropenem Powder Injection Product Portfolio
- 4.7.5 Sumitomo Pharma Recent Developments
- 4.8 PKU HealthCare
- 4.8.1 PKU HealthCare Company Information
- 4.8.2 PKU HealthCare Business Overview
- 4.8.3 PKU HealthCare Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 PKU HealthCare Meropenem Powder Injection Product Portfolio
- 4.8.5 PKU HealthCare Recent Developments
- 4.9 Pfizer
- 4.9.1 Pfizer Company Information
- 4.9.2 Pfizer Business Overview
- 4.9.3 Pfizer Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Pfizer Meropenem Powder Injection Product Portfolio
- 4.9.5 Pfizer Recent Developments
- 4.10 Joincare
- 4.10.1 Joincare Company Information
- 4.10.2 Joincare Business Overview
- 4.10.3 Joincare Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Joincare Meropenem Powder Injection Product Portfolio
- 4.10.5 Joincare Recent Developments
- 4.11 Intelicure Lifesciences
- 4.11.1 Intelicure Lifesciences Company Information
- 4.11.2 Intelicure Lifesciences Business Overview
- 4.11.3 Intelicure Lifesciences Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Intelicure Lifesciences Meropenem Powder Injection Product Portfolio
- 4.11.5 Intelicure Lifesciences Recent Developments
- 4.12 CSPC Pharmaceutical Group
- 4.12.1 CSPC Pharmaceutical Group Company Information
- 4.12.2 CSPC Pharmaceutical Group Business Overview
- 4.12.3 CSPC Pharmaceutical Group Meropenem Powder Injection Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 CSPC Pharmaceutical Group Meropenem Powder Injection Product Portfolio
- 4.12.5 CSPC Pharmaceutical Group Recent Developments
5 Global Meropenem Powder Injection Market Scenario by Region
- 5.1 Global Meropenem Powder Injection Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Meropenem Powder Injection Sales by Region: 2021-2032
- 5.2.1 Global Meropenem Powder Injection Sales by Region: 2021-2026
- 5.2.2 Global Meropenem Powder Injection Sales by Region: 2027-2032
- 5.3 Global Meropenem Powder Injection Revenue by Region: 2021-2032
- 5.3.1 Global Meropenem Powder Injection Revenue by Region: 2021-2026
- 5.3.2 Global Meropenem Powder Injection Revenue by Region: 2027-2032
- 5.4 North America Meropenem Powder Injection Market Facts & Figures by Country
- 5.4.1 North America Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Meropenem Powder Injection Sales by Country (2021-2032)
- 5.4.3 North America Meropenem Powder Injection Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Meropenem Powder Injection Market Facts & Figures by Country
- 5.5.1 Europe Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Meropenem Powder Injection Sales by Country (2021-2032)
- 5.5.3 Europe Meropenem Powder Injection Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Meropenem Powder Injection Market Facts & Figures by Country
- 5.6.1 Asia Pacific Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Meropenem Powder Injection Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Meropenem Powder Injection Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Meropenem Powder Injection Market Facts & Figures by Country
- 5.7.1 South America Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Meropenem Powder Injection Sales by Country (2021-2032)
- 5.7.3 South America Meropenem Powder Injection Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Meropenem Powder Injection Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Meropenem Powder Injection Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Meropenem Powder Injection Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Meropenem Powder Injection Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Meropenem Powder Injection Sales by Type (2021-2032)
- 6.1.1 Global Meropenem Powder Injection Sales by Type (2021-2032) & (K Units)
- 6.1.2 Global Meropenem Powder Injection Sales Market Share by Type (2021-2032)
- 6.2 Global Meropenem Powder Injection Revenue by Type (2021-2032)
- 6.2.1 Global Meropenem Powder Injection Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Meropenem Powder Injection Revenue Market Share by Type (2021-2032)
- 6.3 Global Meropenem Powder Injection Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Meropenem Powder Injection Sales by Application (2021-2032)
- 7.1.1 Global Meropenem Powder Injection Sales by Application (2021-2032) & (K Units)
- 7.1.2 Global Meropenem Powder Injection Sales Market Share by Application (2021-2032)
- 7.2 Global Meropenem Powder Injection Revenue by Application (2021-2032)
- 7.2.1 Global Meropenem Powder Injection Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Meropenem Powder Injection Revenue Market Share by Application (2021-2032)
- 7.3 Global Meropenem Powder Injection Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Meropenem Powder Injection Value Chain Analysis
- 8.1.1 Meropenem Powder Injection Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Meropenem Powder Injection Production Mode & Process
- 8.2 Meropenem Powder Injection Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Meropenem Powder Injection Distributors
- 8.2.3 Meropenem Powder Injection Customers
9 Global Meropenem Powder Injection Analyzing Market Dynamics
- 9.1 Meropenem Powder Injection Industry Trends
- 9.2 Meropenem Powder Injection Industry Drivers
- 9.3 Meropenem Powder Injection Industry Opportunities and Challenges
- 9.4 Meropenem Powder Injection Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst